A detailed history of Dimensional Fund Advisors LP transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 14,648 shares of INMB stock, worth $66,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,648
Holding current value
$66,648
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$4.86 - $9.86 $71,189 - $144,429
14,648 New
14,648 $78,000
Q1 2022

May 13, 2022

SELL
$6.42 - $11.39 $70,953 - $125,882
-11,052 Closed
0 $0
Q4 2020

Feb 25, 2021

BUY
$7.51 - $17.22 $83,000 - $190,315
11,052 New
11,052 $190,000

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $81.7M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.